Research Group Virus Interaction Proteomics

The research group "Virus Interaction Proteomics" is driven by the motivation to understand the biochemical principles underlying virus infection of host cells. Studying the invasion of viruses into susceptible cells and the genome replication of viruses inside cells is at the heart of our work. Using quantitative high resolution proteomics we investigate molecular interactions between viruses and host. In the past years we have elucidated protein interactions during infection with the chronic hepatitis C virus (HCV) and newly emerging viruses including insect-borne viruses and SARS-CoV-2. We ultimately strive to use knowledge on host factors to understand why viruses infect different hosts and tissues and to develop anti-infectives. 

Virus emergence is a global health challenge driven by anthropogenic changes to ecosytems. For instance, climate change has caused the spread of virus-transmitting mosquito species to Europe. Using mosquito-borne alphaviruses such as Chikungunya virus and the recently emerged SARS-CoV-2, we apply our knowledge and proteomics technologies to analyze host protein networks hijacked during virus infection. Our work aims at highlighting similarities and differences of so called zoonotic viruses, i.e. viruses transmitted between animals and humans. This will open new avenues not only towards drug development, but also towards the understanding of host and tissue tropism and thereby towards important predictors of transmission and pathogenesis, i.e. of pandemic potential of viruses. 



Lipid-lowering drugs not a risk factor in COVID-19.

Statins do not increase infectivity or viral replication of SARS-CoV-2

Research projects on SARS-CoV-2 at TWINCORE

Activities concerning novel coronavirus have begun

Protein complex for hepatitis C-virus entry in liver cells is characterised

Hepatitis C virus chronically infects 70 million individuals worldwide. Although the infection can be cured with antiviral drugs, this therapy does…

Robert Koch Foundation Postdoctoral Award for Virology 2017 for Gisa Gerold

Dr. Gisa Gerold received the Robert Koch Foundation Postdoctoral Awards  for Virology 2017 on 3 November  in recognition of her studies on the biology…

Networking-scholarship of the "Deutsche Leberstiftung" for Gisa Gerold

Dr. Gisa Gerold vom Institut für Experimentelle Virologie erhielt anlässlich des 14. HepNet Symposium am 23. Juni 2017 vom Vorsitzenden des…